References
- FaginJAWellsSABiologic and clinical perspectives on thyroid cancerN Engl J Med2016375111054106727626519
- TengHMaoFLiangJTranscriptomic signature associated with carcinogenesis and aggressiveness of papillary thyroid carcinomaTheranostics20188164345435830214625
- ChenDQiWZhangPInvestigation of BRAF V600E detection approaches in papillary thyroid carcinomaPathol Res Pract2018214230330729254799
- KaiserMIEncode and the parts of the human genomeStud Hist Philos Biol Biomed Sci201872283730385203
- DavisCAHitzBCSloanCAThe encyclopedia of DNA elements (encode): data portal updateNucleic Acids Res201846D1D794D80129126249
- ThinKZLiuXFengXRaveendranSTuJCLncRNA-DANCR: a valuable cancer related long non-coding RNA for human cancersPathol Res Pract2018214680180529728310
- AchourCAguiloFLong non-coding RNA and polycomb: an intricate partnership in cancer biologyFront Biosci20182321062132
- Uszczynska-RatajczakBLagardeJFrankishAGuigóRJohnsonRTowards a complete map of the human long non-coding RNA transcriptomeNat Rev Genet201819953554829795125
- YoshimuraHMatsudaYYamamotoMKamiyaSIshiwataTExpression and role of long non-coding RNA H19 in carcinogenesisFront Biosci201823614625
- LiHYuBLiJOverexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancerOncotarget2014582318232924810858
- GuanG-FZhangD-JWenL-JOverexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinomaInt J Med Sci2016131291492227994496
- ShiGLiHGaoFTanQlncRNA H19 predicts poor prognosis in patients with melanoma and regulates cell growth, invasion, migration and epithelial-mesenchymal transition in melanoma cellsOnco Targets Ther2018113583359529950863
- ZhaoJMaS-TDownregulation of lncRNA H19 inhibits migration and invasion of human osteosarcoma through the NF-κB pathwayMol Med Rep20181757388739429568924
- MitchellBDhingraJKMahalingamMBRAF and epithelial-mesenchymal transition: lessons from papillary thyroid carcinoma and primary cutaneous melanomaAdv Anat Pathol201623424427127145091
- KnaufJASartorMAMedvedovicMProgression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signalingOncogene201130283153316221383698
- BaqueroPSánchez-HernándezIJiménez-MoraEOrgazJLJiménezBChiloechesA(V600E)BRAF promotes invasiveness of thyroid cancer cells by decreasing E-cadherin expression through a Snail-dependent mechanismCancer Lett2013335123224123435375
- KimTHKimYNKimHIPrognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinomaOral Oncol201771818628688696
- PaulinCFabienNFuscoADescription of cell line established from human thyroid papillary cancer and secreting human chorionic gonadotropin hormoneC R Acad Sci III199231512493498 French1297527
- RhodesDRKalyana-SundaramSMahavisnoVOncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profilesNeoplasia20079216618017356713
- GaoJAksoyBADogrusozUIntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortalSci Signal20136269pl123550210
- LinH-YZengDLiangY-KWeiX-LChenC-FGATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignanciesOncotarget2017821347503476128423734
- ZengDXiaoYZhuJPengCLiangWLinHKnockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathwayCancer Manag Res20191114315630613163
- ShaukatAAThe rising trend in papillary thyroid carcinoma. True increase or over diagnosis?Saudi Med J201839553129738019
- JillardCLScheriRPSosaJAWhat is the optimal treatment of papillary thyroid cancer?Adv Surg201549799326299491
- QuagliarielloVArmeniaEAurilioCNew treatment of medullary and papillary human thyroid cancer: biological effects of hyaluronic acid hydrogel loaded with quercetin alone or in combination to an inhibitor of Aurora kinaseJ Cell Physiol201623181784179526660542
- HuangYQuSZhuGBRAF V600E Mutation-Assisted risk stratification of solitary Intrathyroidal papillary thyroid cancer for precision treatmentJ Natl Cancer Inst2018110436237029165667
- KwongNMarquseeEGordonMSLong-term, treatment-free survival in select patients with distant metastatic papillary thyroid cancerEndocr Connect20143420721425316293
- PerezDSHoageTRPritchettJRLong, abundantly expressed non-coding transcripts are altered in cancerHum Mol Genet200817564265518006640
- ErhoNBuerkiCTricheTJDavicioniEVergaraIATranscriptome-wide detection of differentially expressed coding and non-coding transcripts and their clinical significance in prostate cancerJ Oncol201220124111
- VuTNPramanaSCalzaSSuoCLeeDPawitanYComprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancerOncotarget2016742688516886327634900
- ZhangTWangY-RZengFCaoH-YZhouH-DWangY-JLncRNA H19 is overexpressed in glioma tissue, is negatively associated with patient survival, and promotes tumor growth through its derivative miR-675Eur Rev Med Pharmacol Sci201620234891489727981546
- ZhangLYangFYuanJ-HangEpigenetic activation of the miR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinomaCarcinogenesis201334357758623222811
- LvJMaLChenX-LHuangX-HWangQDownregulation of LncRNAH19 and miR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathwayJ Huazhong Univ Sci Technolog Med Sci201434336336924939300
- YörükerEEKeskinMKulleCBHoldenriederSGezerUDiagnostic and prognostic value of circulating lncRNA H19 in gastric cancerBiomed Rep20189218118630083318
- SunHWangGPengYH19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cellsOncol Rep20153363045305225846769
- ZhangQLiXLiXLiXChenZLncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cellsJ Cell Biochem201811964447445729219208
- WangPLiuGXuWLiuHBuQSunDLong noncoding RNA H19 inhibits cell viability, migration, and invasion via downregulation of IRS-1 in thyroid cancer cellsTechnol Cancer Res Treat20171661102111229332545
- LanXSunWDongWDownregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinomaGene20186469810529287713
- LiuNZhouQQiY-HWangHYangLFanQ-YEffects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosisExp Mol Pathol20171031717728655518
- LiuLYangJZhuXLiDLvZZhangXLong noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancerFebs J2016283122326233927093644
- JiaLTianYChenYZhangGThe silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-catenin pathwayOnco Targets Ther20181131332129391808
- MatoukIJHalleDRavehEGilonMSorinVHochbergAThe role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decisionOncotarget2016743748376526623562
- ZhouWYeX-LXuJThe lncRNA H19 mediates breast cancer cell plasticity during EMT and Met plasticity by differentially sponging miR-200b/c and let-7bSci Signal201710483eaak955713
- VoonDCHuangRYJacksonRAThieryJPThe EMT spectrum and therapeutic opportunitiesMol Oncol201711787889128544151
- LiaoZZhaoJYangYDownregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NFκB and PI3K/Akt signaling pathwaysMol Med Rep20181757313731829568965